Semaglutide

Semaglutide (Ozempic, Wegovy, Rybelsus) es un medicamento antidabetic contra le diabete de typo 2 (ligate al obesitate).

Serea effictive contra le renal insufficientia chronic.https://bwhealthcareworld.businessworld.in/article/Novo-Nordisk-To-Stop-Trial-Of-Ozempic-For-Kidney-Failure-Treatment/11-10-2023-494538/

Malversate uso
Le uso inappropriate del semaglutide pro su anorectic (appetito reprimente) proprietates in non-diabetic patientes es contraindicate: pote causar secundari effectos como gastrointestinal disordine, pancreatite o hypoglycemia.

Categoria:Medicamento